Home › Head and Neck Cancer › Kentucky › Louisville
Head and Neck Cancer clinical trials in Louisville, KY
3 studies for Head and Neck Cancer are looking for participants at sites in and around Louisville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
RecruitingPhase 2/3
- Site#0111, Louisville
- Site#0115, Louisville
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
RecruitingPhase 1/2
- Norton Cancer Institute, Louisville
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RecruitingObservational studyHealthy volunteers welcome
- Baptist Floyd, New Albany · 4 mi away
About Head and Neck Cancer
Head and neck cancer includes cancers of the mouth, nose, sinuses, salivary glands, throat, and lymph nodes. Read the different symptoms of each type.
More about Head and Neck Cancer on MedlinePlus
Head and Neck Cancer trials in other cities
- Houston, TX30 studies
- Boston, MA22 studies
- Nashville, TN21 studies
- New York City, NY21 studies
- St. Louis, MO15 studies
- Dallas, TX12 studies
- Pittsburgh, PA11 studies
- Los Angeles, CA10 studies
- San Antonio, TX10 studies
- Washington, DC10 studies
- Baltimore, MD10 studies
- Durham, NC10 studies
Other studies in Louisville
- Non-Small Cell Lung Cancer22 studies
- Obesity17 studies
- Overweight15 studies
- Cancer (all types)14 studies
- Heart Failure13 studies
- Acute Myeloid Leukemia12 studies
- Multiple Myeloma12 studies
- Ovarian Cancer12 studies
- Breast Cancer11 studies
- Head and Neck Squamous Cell Carcinoma11 studies
- Lung Cancer11 studies
- Melanoma10 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.